| EMA number | EMEA/H/C/001132 |
| ATC code | B01AC04 |
| Authorisation | 21 July 2009 |
| Withdrawn | 5 May 2015 |
| Revision | 6 |
Clopidogrel is indicated in adults for the prevention of atherothrombotic events in: Patients suffering from myocardial infarction (from a few days until less than 35 days), ischaemic stroke (from 7 days until less than 6 months) or established peripheral arterial disease.